News
Oliver Healthcare Packaging clinches Packaging Design of the Year Award
Singapore’s Oliver Healthcare Packaging received the Packaging Design of the Year Award at the recently concluded Healthcare Asia Pharma Awards 2020.
The award recognised the company’s proprietary Autoclavable Dispos-a-vent® Barrier Pouch, which provides medical device manufacturers a pouch option for...
Press Releases
INOVIO Expands Manufacturing of COVID-19 DNAVaccine INO-4800 With New Funding from CEPI
INOVIO announced it has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG, to support large-scale manufacturing of INOVIO's investigational DNA vaccine INO-4800, which currently is in Phase...
News
Massachusetts Hospital to Assess Mallinckrodt’s Nitric Oxide Treatment for COVID-19
Mallinckrodt and Massachusetts General Hospital teamed up to evaluate the potential benefits of inhaled nitric oxide as a treatment for pulmonary complications in patients infected with COVID-19.
The partnership will assess the benefit of INOmax (nitric oxide) gas in mechanically...
Press Releases
Geneius Develops Off-the-Shelf T Cell Therapy Targeting SARS-CoV-2
Geneius Biotechnology is developing T cells as a quasi-personalized, off-the-shelf, therapy and preventive measure against COVID-19. The assumption is that by increasing the number of antigen-specific T cells in the body, the patient’s immune system can overwhelm the SARS-CoV-2...
News
Gilead’s drug remdesivir gets US FDA’s emergency use authorisation for COVID-19
Gilead was granted EUA by U.S. FDA for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at additional hospitals across...
Press Releases
Hardy Diagnostics announces FDA EUA for antibody test and increases manufacturing capacity for COVID-19 products
Hardy Diagnostics, a medical device manufacturer based in Santa Maria, California, announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test (Cat. No. RTA0203).
This immunoassay is intended for qualitative detection and...
Clinical Trials
A World Pharma Today exclusive with Jim Murphy, CEO, Greenphire
Who would have thought a pandemic in this modern era would cripple the world, the strongest economies would be shaken, and end up being so vulnerable despite having the most modern technologies and processes at our disposal. That being...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
















